Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01161953 · ClinicalTrials.gov registry record
Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,500
- Enrollment target
NCT01161953: Completed study, sponsored by Mayo Clinic.
NCT01161953 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01161953 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
Study Summary
Primary Biliary Cirrhosis (PBC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC. This study is being done to investigate whether genes make people more likely to develop PBC. Discovery of these proposed genes will help us better understand how PBC developes, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.
Interventions
- GENETIC Genetic Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2002-03 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01161953
The ClinicalTrials.gov registry entry for NCT01161953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genetic Analysis is the first listed.
NCT01161953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01161953 about?
NCT01161953 is a clinical study titled "Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)". Primary Biliary Cirrhosis (PBC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC. This study is being done to i...
What is the current status of trial NCT01161953?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2002-03. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT01161953?
The interventions under investigation include: Genetic Analysis (GENETIC).
Who is sponsoring clinical trial NCT01161953?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.